Tech Company Financing Transactions
Freya Biosciences Funding Round
Freya Biosciences, based in Copenhagen, scored $11.8 million from Bill & Melinda Gates Foundation and EIFO.
Transaction Overview
Company Name
Announced On
11/19/2024
Transaction Type
Venture Equity
Amount
$11,800,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to develop microbial immunotherapies for the treatment of bacterial vaginosis (BV) to address pre-term birth and potentially other indications affecting maternal and newborn health.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Fruebjergvej 3
Copenhagen, 2100
DK
Copenhagen, 2100
DK
Phone
Undisclosed
Website
Email Address
Overview
Freya� is a clinical-stage company taking an innovative approach to women's health, with microbial immunotherapies aimed at relieving the chronic inflammation underlying a range of reproductive system diseases uniquely afflicting women. Insufficient research and limited treatment options for infertility and endometrial disorders means women -- and their families -- are often left struggling for answers. At Freya, we're united by a relentless drive to advance innovative solutions and provide real hope and viable new treatment options for women around the world.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Colleen Acosta
Chief Marketing Officer
Joan Arce
Co-Founder
Ulrich Binné
Browse more venture capital transactions:
Prev: 11/19/2024: SuperScale venture capital transaction
Next: 11/19/2024: Agentio venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs